N-terminal and core-domain random mutations in human topoisomerase II α conferring bisdioxopiperazine resistance
- 30 August 2000
- journal article
- Published by Wiley in FEBS Letters
- Vol. 480 (2-3) , 201-207
- https://doi.org/10.1016/s0014-5793(00)01934-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Essential Mitotic Functions of DNA Topoisomerase IIα Are Not Adopted by Topoisomerase IIβ in Human H69 CellsJournal of Biological Chemistry, 1998
- Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: a potent tool for identification and characterization of topoisomerase II-targeting antitumour agentsCancer Chemotherapy and Pharmacology, 1998
- Analysis of a Core Domain in Drosophila DNA Topoisomerase IIPublished by Elsevier ,1998
- The Bis(naphthalimide) DMP-840 Causes Cytotoxicity by Its Action against Eukaryotic Topoisomerase IIBiochemistry, 1998
- Structure and mechanism of DNA topoisomerase IINature, 1996
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- Antitumor bisdioxopiperazines inhibit yeast DNAtopoisomerase II by trapping the enzyme in the form of a closed proteinclamp.Proceedings of the National Academy of Sciences, 1994
- Crystal structure of an N-terminal fragment of the DNA gyrase B proteinNature, 1991
- [21] Recovery of plasmids from yeast into Escherichia coli: Shuttle vectorsPublished by Elsevier ,1991
- A quantitative decatenation assay for type II topoisomerasesAnalytical Biochemistry, 1986